Literature DB >> 22874670

Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease.

Olga Calero1, María J Bullido, Jordi Clarimón, Rafael Hortigüela, Ana Frank-García, Pablo Martínez-Martín, Alberto Lleó, María Jesús Rey, Isabel Sastre, Alberto Rábano, Jesús de Pedro-Cuesta, Isidro Ferrer, Miguel Calero.   

Abstract

Perturbations of calcium homeostasis have been associated with several neurodegenerative disorders. A common polymorphism (rs2986017) in the CALHM1 gene, coding for a regulator of calcium homeostasis, is a genetic risk factor for the development of Alzheimer disease (AD). Although some authors failed to confirm these results, a meta-analysis has shown that this polymorphism modulates the age at disease onset. Furthermore, a recent association study has explored the genetic variability of CALHM1 gene and two adjacent paralog genes (CALHM3 and CALHM2) in an Asian population. Since several lines of evidence suggest that AD and prion diseases share pathophysiologic mechanisms, we investigated for the first time the genetic variability of the gene cluster formed by CALHM1 and its paralogs in a series of 235 sporadic Creutzfeldt-Jakob disease (sCJD) patients, and compared the genotypic and allelic frequencies with those presented in 329 controls from the same ancestry. As such, this work also represents the first association analysis of CALHM genes in sCJD. Sequencing analysis of the complete coding regions of the genes demonstrated the presence of 10 single nucleotide polymorphisms (SNP) within the CALHM genes. We observed that rs4918016-rs2986017-rs2986018 and rs41287502-rs41287500 polymorphic sites at CALHM1 were in linkage disequilibrium. We found marginal associations for sCJD risk at CALHM1 polymorphic sites rs41287502 and rs41287500 [coding for two linked missense mutations (p.(Met323Ile); (Gly282Cys)], and rs2986017 [p.(Leu86Pro)]. Interestingly, a TGG haplotype defined by the rs4918016-rs2986017-rs2986018 block was associated with sCJD. These findings underscore the need of future multinational collaborative initiatives in order to corroborate these seminal data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874670      PMCID: PMC3609071          DOI: 10.4161/pri.20785

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  34 in total

1.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

Review 2.  Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.

Authors:  D L Price; D R Borchelt; S S Sisodia
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 3.  Disruption of calcium homeostasis in the pathogenesis of Alzheimer's disease and other conformational diseases.

Authors:  Masahiro Kawahara
Journal:  Curr Alzheimer Res       Date:  2004-05       Impact factor: 3.498

4.  The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.

Authors:  Jean-Charles Lambert; Kristel Sleegers; Antonio González-Pérez; Martin Ingelsson; Gary W Beecham; Mikko Hiltunen; Onofre Combarros; Maria J Bullido; Nathalie Brouwers; Karolien Bettens; Claudine Berr; Florence Pasquier; Florence Richard; Steven T Dekosky; Didier Hannequin; Jonathan L Haines; Gloria Tognoni; Nathalie Fiévet; Jean-François Dartigues; Christophe Tzourio; Sebastiaan Engelborghs; Beatrice Arosio; Elicer Coto; Peter De Deyn; Maria Del Zompo; Ignacio Mateo; Merce Boada; Carmen Antunez; Jesus Lopez-Arrieta; Jacques Epelbaum; Brit-Maren Michaud Schjeide; Ana Frank-Garcia; Vilmentas Giedraitis; Seppo Helisalmi; Elisa Porcellini; Alberto Pilotto; Paola Forti; Raffaele Ferri; Marc Delepine; Diana Zelenika; Mark Lathrop; Elio Scarpini; Gabriele Siciliano; Vincenzo Solfrizzi; Sandro Sorbi; Gianfranco Spalletta; Giovanni Ravaglia; Fernando Valdivieso; Saila Vepsäläinen; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Olivier Hanon; Paola Piccardi; Giorgio Annoni; David Mann; Philippe Marambaud; Davide Seripa; Daniela Galimberti; Rudolph E Tanzi; Lars Bertram; Corinne Lendon; Lars Lannfelt; Federico Licastro; Dominique Campion; Margaret A Pericak-Vance; Hilkka Soininen; Christine Van Broeckhoven; Annick Alpérovitch; Agustin Ruiz; M Ilyas Kamboh; Philippe Amouyel
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Mech Ageing Dev       Date:  2010-05-20       Impact factor: 5.432

6.  No association between CALHM1 variation and risk of Alzheimer disease.

Authors:  Ryan L Minster; F Yesim Demirci; Steven T DeKosky; M Ilyas Kamboh
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

7.  No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.

Authors:  Kristel Sleegers; Nathalie Brouwers; Karolien Bettens; Sebastiaan Engelborghs; Helen van Miegroet; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

8.  Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.

Authors:  Nobuto Shibata; Bolati Kuerban; Miwa Komatsu; Tohru Ohnuma; Hajime Baba; Heii Arai
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.

Authors:  Benedetta Nacmias; Andrea Tedde; Silvia Bagnoli; Ersilia Lucenteforte; Elena Cellini; Irene Piaceri; Bianca Maria Guarnieri; Valentina Bessi; Laura Bracco; Sandro Sorbi
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more
  9 in total

1.  RARB and STMN2 polymorphisms are not associated with sporadic Creutzfeldt-Jakob disease (CJD) in the Korean population.

Authors:  Byung-Hoon Jeong; Hae-Jung Kim; Kyung-Hee Lee; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

2.  Analyses of the mitochondrial mutations in the Chinese patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Jin Zhang; Zhi-Xia Zhang; Peng-Chen Du; Wei Zhou; Su-Dong Wu; Qi-Ling Wang; Cao Chen; Qi Shi; Chen Chen; Chen Gao; Chan Tian; Xiao-Ping Dong
Journal:  Eur J Hum Genet       Date:  2014-03-26       Impact factor: 4.246

3.  Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI.

Authors:  Benjamin F J Verhaaren; Stéphanie Debette; Joshua C Bis; Jennifer A Smith; M Kamran Ikram; Hieab H Adams; Ashley H Beecham; Kumar B Rajan; Lorna M Lopez; Sandra Barral; Mark A van Buchem; Jeroen van der Grond; Albert V Smith; Katrin Hegenscheid; Neelum T Aggarwal; Mariza de Andrade; Elizabeth J Atkinson; Marian Beekman; Alexa S Beiser; Susan H Blanton; Eric Boerwinkle; Adam M Brickman; R Nick Bryan; Ganesh Chauhan; Christopher P L H Chen; Vincent Chouraki; Anton J M de Craen; Fabrice Crivello; Ian J Deary; Joris Deelen; Philip L De Jager; Carole Dufouil; Mitchell S V Elkind; Denis A Evans; Paul Freudenberger; Rebecca F Gottesman; Vilmundur Guðnason; Mohamad Habes; Susan R Heckbert; Gerardo Heiss; Saima Hilal; Edith Hofer; Albert Hofman; Carla A Ibrahim-Verbaas; David S Knopman; Cora E Lewis; Jiemin Liao; David C M Liewald; Michelle Luciano; Aad van der Lugt; Oliver O Martinez; Richard Mayeux; Bernard Mazoyer; Mike Nalls; Matthias Nauck; Wiro J Niessen; Ben A Oostra; Bruce M Psaty; Kenneth M Rice; Jerome I Rotter; Bettina von Sarnowski; Helena Schmidt; Pamela J Schreiner; Maaike Schuur; Stephen S Sidney; Sigurdur Sigurdsson; P Eline Slagboom; David J M Stott; John C van Swieten; Alexander Teumer; Anna Maria Töglhofer; Matthew Traylor; Stella Trompet; Stephen T Turner; Christophe Tzourio; Hae-Won Uh; André G Uitterlinden; Meike W Vernooij; Jing J Wang; Tien Y Wong; Joanna M Wardlaw; B Gwen Windham; Katharina Wittfeld; Christiane Wolf; Clinton B Wright; Qiong Yang; Wei Zhao; Alex Zijdenbos; J Wouter Jukema; Ralph L Sacco; Sharon L R Kardia; Philippe Amouyel; Thomas H Mosley; W T Longstreth; Charles C DeCarli; Cornelia M van Duijn; Reinhold Schmidt; Lenore J Launer; Hans J Grabe; Sudha S Seshadri; M Arfan Ikram; Myriam Fornage
Journal:  Circ Cardiovasc Genet       Date:  2015-02-07

Review 4.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

5.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  A missense variant in specificity protein 6 (SP6) is associated with amelogenesis imperfecta.

Authors:  Claire E L Smith; Laura L E Whitehouse; James A Poulter; Laura Wilkinson Hewitt; Fatima Nadat; Brian R Jackson; Iain W Manfield; Thomas A Edwards; Helen D Rodd; Chris F Inglehearn; Alan J Mighell
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

7.  Cryo-EM structures of human calcium homeostasis modulator 5.

Authors:  Jie Liu; Futang Wan; Qiuheng Jin; Xiaoxiao Li; Eijaz Ahmed Bhat; Jiangtao Guo; Ming Lei; Fenghui Guan; Jian Wu; Sheng Ye
Journal:  Cell Discov       Date:  2020-11-10       Impact factor: 10.849

8.  A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Isabel Sastre; Alberto Rábano; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

9.  Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; María Ruiz-Tovar; Enrique Alcalde-Cabero; Miguel Calero
Journal:  Front Aging Neurosci       Date:  2016-06-13       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.